# Phase 12 Internal Verification — Advanced Quant Research

**Status:** COMPLETE / CONDITIONAL GO — REAL SCIENTIFIC EVALUATION REQUIRED
**Hypothesis:** `HYP-EVENT-001A`
**Dataset:** `hyp-event-001a-sec-8k-alpaca-sip-2016-2025-v1`
**Dataset manifest:** `db2b454793e50f28c34c9c2a7d91f798741936528752de7bd27cb52072a4864d`

## Package commits

| Package | Commit | Result |
|---|---|---|
| WP-12.01 suitability spike | `687fca5` | Existing Jax architecture retained; Qlib/RD-Agent not justified |
| WP-12.02 feature/factor contract | `342ba02` | Event-time provenance and explicit unknown semantics |
| WP-12.03 leakage-safe experiment framework | `6a403dd` | Frozen partitions, sealed holdout and one-way OOS |
| WP-12.04 factor mining/stability | `41e80ec` | Bounded trial ledger and complete falsification suite |
| WP-12.05 model selection/ensembles | `3ba7b03` | Validation-only selection; baseline and ensemble guards |
| WP-12.06 drift/retraining | `08e088b` | Drift states and non-overlapping rolling windows |
| WP-12.07 experiment registry | `833630a` | Immutable variants and deterministic rejection outcomes |
| WP-12.08 promotion gate | `d3b6a64` | Fail-closed promotion with no recommendation mutation |
| Adversarial hardening | `58291db` | Partition-crossing and promotion-consistency regressions |
| Artifact immutability hardening | `921704e`, `7617279`, `532bf22` | Defensive copies and sealed frozen OOS configuration |

## Architecture and scientific boundary

Phase 12 uses the existing Go modular-monolith, `libs/dataset`, replay/
evaluation contracts and immutable local artifacts. No Python runtime, Qlib,
RD-Agent, Ray, Spark, GPU, feature-store service, vector database, external
experiment service or hosted inference was introduced.

The feature contract binds event, dataset, source, availability timestamp,
calculation timestamp, algorithm/version, parameters and `KNOWN`, `UNKNOWN` or
`NOT_ELIGIBLE` state. The experiment protocol freezes the dataset, hypothesis,
partitions, horizons, benchmark, metric and cost-model identity. Formal OOS is
2024 and can be scored only once after configuration freeze. The 2025 final
holdout is rejected by the framework and was not read for outcomes.

The registered falsification suite covers shuffled labels/dates, placebo dates,
quality permutation, source removal, issuer/event clustering, liquidity
sensitivity, cost stress, regime split and top-issuer exclusion. Every trial is
retained in the immutable registry.

Model selection uses development/validation only and requires cost-adjusted
validation evidence. Drift supports `VALID`, `DEGRADED`, `REJECTED` and related
research states. Rolling windows require training to end before evaluation.

## Results and promotion

The exit harness runs a synthetic event-time-safe fixture through direction-only
and evidence-conditioned baselines, validation selection, a single frozen 2024
OOS capability run, stability/falsification checks, registry recording and drift
monitoring. It demonstrates deterministic reproducibility and failure paths.

The private HYP-EVENT-001A panel has been extended with immutable SEC
accession-time evidence packets in the derived local dataset
`hyp-event-001a-sec-8k-alpaca-sip-2016-2025-evidence-v2`, bound to the accepted
parent manifest. Coverage is 1,059/1,059 primary documents, 10,731 inventory
rows, 2,418 selected raw text documents and zero retrieval failures. The 2024
content remains semantically sealed until classifier freeze and 2025 remains
hash/inventory-only and sealed for semantic/outcome use. The direction contract
`jax.hyp-event-001a.direction/v1` is frozen with prompt identity
`d0b09acf412eb73ff97fc2e9bd5f4fc609dc57d5bd1dbd17d57f986b158d4143`; no bulk
hosted-model classification was run and no inference cost was incurred. The
existing unversioned keyword helper remains inadmissible. No real
HYP-EVENT-001A performance, effect size, falsification result or scientific OOS
conclusion is claimed. The current stop is the hosted-inference cost gate;
the proposed one-time maximum envelope is $6.00, while the active ceiling is
$0.

No advanced model was trained or promoted. The promotion gate is deterministically
`PROMOTION_CLOSED` because the final holdout is sealed, survivorship remains
unresolved and actual forward-paper evidence is `0 DAYS / 0 ORDERS`.
Recommendation logic and paper/live authority are unchanged.

## Exit proof

The Phase-12 exit condition is demonstrated at capability level:

`NO ADVANCED MODEL AFFECTS RECOMMENDATIONS UNTIL IT BEATS DEFINED BASELINES OUT-OF-SAMPLE, IS REPRODUCIBLE, AND HAS MONITORING/DRIFT/FAILURE BEHAVIOUR.`

Evidence: sealed-holdout rejection, validation-only selection, one-way OOS,
complete trial/falsification retention, deterministic drift/failure states and
promotion closure with `RecommendationMutationAllowed=false`.

## Safety and limitations

- `ALLOW_LIVE_TRADING=false`.
- `BROKER_EXECUTION_ALLOWED=false`.
- Live worker disabled; maximum leverage remains 1x.
- No recommendation, approval, paper order, live order, trade, fill or portfolio
  mutation is created by Phase 12.
- `TRADING EDGE NOT DEMONSTRATED / INSUFFICIENT SAMPLE` remains unchanged.
- Actual forward-paper evidence remains `0 DAYS / 0 ORDERS`.
- Native-host race detection remains unavailable because gcc/cgo is absent. The
  required existing Docker environment was subsequently used successfully:
  `CGO_ENABLED=1 go test -race ./internal/modules/workflow
  ./internal/modules/papertrading -count=1` passed. This resolves the tracked
  Phase-10/11 race-verification condition for the tested packages; it is not a
  claim that native Windows tooling has cgo enabled.
- Current-ticker survivorship and corporate-action limitations remain; promotion
  is closed until independently resolved.

## Verification commands

- `go test ./internal/modules/advancedquant -count=1`
- `go test ./... -count=1`
- `go vet ./...`
- `docker run ... golang:1.26.6 ... go test -race ./internal/modules/workflow ./internal/modules/papertrading -count=1`
- `git diff --check`
- roadmap JSON and manifest validation

Final phase review requires fresh adversarial review over the Phase-12 start
HEAD through the final HEAD. The phase may be presented for external review only
with zero blocking findings and no Phase 13 implementation.
